Krupnick, Ryan, John – Trademark Portfolio

Entity Type: 01

Krupnick, Ryan, John holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 2 (Paints) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include STEM CELL SCALP MICROPIGMENTATION. The owner is based in Spring Hill, FL.

4121 Braemere Dr

Spring Hill, FL 34609

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Krupnick, Ryan, John's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

2
Paints (1 filing)

Paints, varnishes, lacquers; preservatives against rust and against deterioration of wood

Frequently Asked Questions

How many trademarks does Krupnick, Ryan, John have?

Krupnick, Ryan, John has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.

What trademark classes does Krupnick, Ryan, John file in?

Krupnick, Ryan, John files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 2 (Paints). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Krupnick, Ryan, John's most well-known trademarks?

Krupnick, Ryan, John's registered trademark portfolio includes well-known marks such as STEM CELL SCALP MICROPIGMENTATION. These are among 1 currently registered trademark in the portfolio.

What is Krupnick, Ryan, John's trademark registration success rate?

Krupnick, Ryan, John has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.